|
A separate report will be submitted pertaining to the second pipeline used in the event with model no.Ped2-475-12.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Product analysis: equipment used: video inspection system (m-78210), ruler (m-83361), pin gauge sets (m-84083, m-84081), camera (panasonic lumix dmc-zs5), 0.0265¿ mandrel as found condition: the pipeline flex w/ shield device and phenom-27 micro catheter were returned for analysis within shipping box and within two sealed plastic biohazard pouches.Visual inspection/damage location details: no damages or irregularities were found with the phenom-27 catheter hub.Small specks of dried blood were found within the hub.The pipeline flex w/ shield pusher was found extending out the hub ~44.4cm.The phenom-27 micro catheter was found kinked at ~0.3cm form the distal end.No damages or irregularities were found with the distal tip or marker band.The distal braid and tip coil were found extending out the distal tip of the micro catheter.The pipeline flex w/ shield was advanced out with resistance encountered.The hypotube was found unstretched and undamaged with the ptfe shrink tubing still intact.The distal marker, re-sheathing marker and proximal bumper were found loose on the distal wire.The distal and proximal dps restraints were found to be intact.The dps sleeves were found intact with no signs of damage.The tip coil was found intact.Both braid ends were found fully opened, damaged and frayed.Testing/analysis: the phenom-27 micro catheter total length was measured to be ~158.6 and the usable length was measured to be ~152.1cm, which is within specification (specification: total (ref) = 156.5cm, usable = 150cm ± 5cm).The inner diameter of the micro catheter was measured to be 0.0265¿ at the distal end and 0.0270¿ at the proximal end, which is within specification (specification: 0.027¿ ± 0.001¿).A 0.0265¿ mandrel was inserted into the phenom-27 micro catheter hub, through the catheter body out the distal tip with resistance felt at the kinked location (~0.3cm from the distal end).Conclusion: based on the analysis findings, the customer report of ¿failure/incomplete open distal (flex)¿ could not be confirmed as both braid ends were found fully opened.Possible causes are patient vessel tortuosity, damaged braid, braid improperly sized to anatomy, braid was overstretched during delivery, user deploys braid in vessel braid, presence of other indwelling stents or inappropriate anatomy.The braid was found damaged.Potential causes for braid damage are resheathing more than 2 times, high force delivery, over-manipulation, delivering/retracting delivery wire against resistance, deploying/resheathing braid against resistance, or damage during return shipping as the distal braid was returned already deployed out of the distal tip.The customer report of ¿resistance during re-sheathing/failure to resheath¿ and ¿catheter resheathing¿ was confirmed.The kink found on the catheter was found to contribute towards the resheathing.Possible causes for catheter kinking are patient vessel tortuosity, guidewire or delivery system removed aggressively, catheter entrapment, or user advances/retrieves the device against resistance.Customer reported pipeline was resheathed 3 times, device was not positioned in a vessel bend, continuous flush was administered, all devices were prepared per ifu, and patient vessel tortuosity as severe.It is possible the 3 times resheathing contributed towards the braid damage.The braid damage and the severe tortuosity contributed towards the failure to open and the resistance.The resheathing pad, resheathing marker and proximal bumper were found loose on the distal wire, likely due to advancing/retracting against the reported resistance.No non-conformance to specifications were found that would contribute towards the reported failures.H6.Coding updated based an analysis results.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|